annual EBIT:
-$301.54M+$190.96M(+38.77%)Summary
- As of today (August 20, 2025), ASND annual earnings before interest & taxes is -$301.54 million, with the most recent change of +$190.96 million (+38.77%) on December 31, 2024.
- During the last 3 years, ASND annual EBIT has risen by +$232.47 million (+43.53%).
- ASND annual EBIT is now -4402.42% below its all-time high of $7.01 million, reached on December 31, 2013.
Performance
ASND EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$60.06M+$49.62M(+45.24%)Summary
- As of today (August 20, 2025), ASND quarterly earnings before interest & taxes is -$60.06 million, with the most recent change of +$49.62 million (+45.24%) on June 1, 2025.
- Over the past year, ASND quarterly EBIT has increased by +$83.39 million (+58.13%).
- ASND quarterly EBIT is now -2034.42% below its all-time high of $3.10 million, reached on December 31, 2013.
Performance
ASND quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$275.61M+$83.39M(+23.23%)Summary
- As of today (August 20, 2025), ASND TTM earnings before interest & taxes is -$275.61 million, with the most recent change of +$83.39 million (+23.23%) on June 1, 2025.
- Over the past year, ASND TTM EBIT has increased by +$106.77 million (+27.92%).
- ASND TTM EBIT is now -5137.40% below its all-time high of $5.47 million, reached on December 31, 2013.
Performance
ASND TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
ASND EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +38.8% | +58.1% | +27.9% |
| 3 y3 years | +43.5% | +60.2% | +48.7% |
| 5 y5 years | -18.8% | +34.3% | +9.3% |
ASND EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +48.9% | <-9999.0% | +61.0% | at high | +54.4% |
| 5 y | 5-year | -18.8% | +48.9% | <-9999.0% | +61.0% | at high | +54.4% |
| alltime | all time | -4402.4% | +48.9% | -2034.4% | +61.0% | -5137.4% | +54.4% |
ASND EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$60.06M(-45.2%) | -$275.61M(-23.2%) |
| Mar 2025 | - | -$109.68M(<-9900.0%) | -$359.00M(+18.6%) |
| Dec 2024 | -$301.54M(-38.8%) | $408.50K(-100.4%) | -$302.66M(-11.6%) |
| Sep 2024 | - | -$106.28M(-25.9%) | -$342.44M(-10.4%) |
| Jun 2024 | - | -$143.46M(+168.9%) | -$382.38M(-2.5%) |
| Mar 2024 | - | -$53.34M(+35.5%) | -$392.20M(-20.5%) |
| Dec 2023 | -$492.49M(-16.6%) | -$39.37M(-73.1%) | -$493.03M(-18.4%) |
| Sep 2023 | - | -$146.21M(-4.6%) | -$604.00M(+0.1%) |
| Jun 2023 | - | -$153.28M(-0.6%) | -$603.26M(+0.4%) |
| Mar 2023 | - | -$154.17M(+2.5%) | -$600.99M(+1.8%) |
| Dec 2022 | -$590.45M(+10.6%) | -$150.34M(+3.3%) | -$590.46M(+3.8%) |
| Sep 2022 | - | -$145.48M(-3.7%) | -$568.80M(+5.8%) |
| Jun 2022 | - | -$151.01M(+5.1%) | -$537.58M(+1.7%) |
| Mar 2022 | - | -$143.63M(+11.6%) | -$528.38M(-1.2%) |
| Dec 2021 | -$534.01M(+41.7%) | -$128.68M(+12.6%) | -$534.89M(+2.8%) |
| Sep 2021 | - | -$114.26M(-19.4%) | -$520.24M(+4.4%) |
| Jun 2021 | - | -$141.82M(-5.5%) | -$498.11M(+11.3%) |
| Mar 2021 | - | -$150.14M(+31.7%) | -$447.64M(+18.4%) |
| Dec 2020 | -$376.90M(+48.5%) | -$114.02M(+23.8%) | -$378.15M(+12.6%) |
| Sep 2020 | - | -$92.13M(+0.9%) | -$335.92M(+10.6%) |
| Jun 2020 | - | -$91.35M(+13.3%) | -$303.85M(+12.3%) |
| Mar 2020 | - | -$80.65M(+12.3%) | -$270.45M(+6.6%) |
| Dec 2019 | -$253.75M | -$71.80M(+19.5%) | -$253.71M(+13.9%) |
| Sep 2019 | - | -$60.06M(+3.6%) | -$222.82M(+7.5%) |
| Jun 2019 | - | -$57.95M(-9.3%) | -$207.30M(+1.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$63.91M(+56.2%) | -$203.47M(+11.3%) |
| Dec 2018 | -$182.57M(+45.1%) | -$40.91M(-8.1%) | -$182.79M(+1.9%) |
| Sep 2018 | - | -$44.53M(-17.7%) | -$179.37M(+4.4%) |
| Jun 2018 | - | -$54.12M(+25.2%) | -$171.80M(+18.6%) |
| Mar 2018 | - | -$43.23M(+15.3%) | -$144.85M(+14.3%) |
| Dec 2017 | -$125.81M(+56.0%) | -$37.49M(+1.4%) | -$126.74M(+11.9%) |
| Sep 2017 | - | -$36.97M(+36.1%) | -$113.21M(+17.5%) |
| Jun 2017 | - | -$27.17M(+8.2%) | -$96.31M(+12.2%) |
| Mar 2017 | - | -$25.11M(+4.8%) | -$85.87M(+6.7%) |
| Dec 2016 | -$80.66M(+73.9%) | -$23.96M(+19.4%) | -$80.48M(+12.0%) |
| Sep 2016 | - | -$20.07M(+20.0%) | -$71.85M(+19.9%) |
| Jun 2016 | - | -$16.72M(-15.2%) | -$59.92M(+4.4%) |
| Mar 2016 | - | -$19.73M(+28.7%) | -$57.40M(+52.4%) |
| Dec 2015 | -$46.38M(+191.7%) | -$15.33M(+88.5%) | -$37.67M(+20.9%) |
| Sep 2015 | - | -$8.13M(-42.8%) | -$31.16M(+19.9%) |
| Jun 2015 | - | -$14.21M(<-9900.0%) | -$25.99M(+120.5%) |
| Mar 2015 | - | $0.00(-100.0%) | -$11.79M(-5.5%) |
| Dec 2014 | -$15.90M(-326.9%) | -$8.82M(+197.5%) | -$12.47M(+2199.0%) |
| Sep 2014 | - | -$2.96M(<-9900.0%) | -$542.30K(-111.3%) |
| Jun 2014 | - | $0.00(-100.0%) | $4.79M(0.0%) |
| Mar 2014 | - | -$682.30K(-122.0%) | $4.79M(-12.5%) |
| Dec 2013 | $7.01M(+260.6%) | $3.10M(+31.2%) | $5.47M(+131.2%) |
| Sep 2013 | - | $2.37M(>+9900.0%) | $2.37M(>+9900.0%) |
| Jun 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2013 | - | $0.00 | $0.00 |
| Dec 2012 | $1.94M | - | - |
FAQ
- What is Ascendis Pharma A/S annual earnings before interest & taxes?
- What is the all time high annual EBIT for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S annual EBIT year-on-year change?
- What is Ascendis Pharma A/S quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S quarterly EBIT year-on-year change?
- What is Ascendis Pharma A/S TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S TTM EBIT year-on-year change?
What is Ascendis Pharma A/S annual earnings before interest & taxes?
The current annual EBIT of ASND is -$301.54M
What is the all time high annual EBIT for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high annual earnings before interest & taxes is $7.01M
What is Ascendis Pharma A/S annual EBIT year-on-year change?
Over the past year, ASND annual earnings before interest & taxes has changed by +$190.96M (+38.77%)
What is Ascendis Pharma A/S quarterly earnings before interest & taxes?
The current quarterly EBIT of ASND is -$60.06M
What is the all time high quarterly EBIT for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high quarterly earnings before interest & taxes is $3.10M
What is Ascendis Pharma A/S quarterly EBIT year-on-year change?
Over the past year, ASND quarterly earnings before interest & taxes has changed by +$83.39M (+58.13%)
What is Ascendis Pharma A/S TTM earnings before interest & taxes?
The current TTM EBIT of ASND is -$275.61M
What is the all time high TTM EBIT for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high TTM earnings before interest & taxes is $5.47M
What is Ascendis Pharma A/S TTM EBIT year-on-year change?
Over the past year, ASND TTM earnings before interest & taxes has changed by +$106.77M (+27.92%)